Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ACLX | 47.50% | $3.59B | +20.28% | 0.00% |
OCUL | 47.27% | $1.26B | +108.05% | 0.00% |
CRSP | 43.98% | $3.46B | -34.62% | 0.00% |
G | 43.67% | $7.96B | +27.57% | 1.31% |
ALLO | 42.26% | $381.60M | -41.10% | 0.00% |
DNLI | 41.72% | $3.16B | +28.32% | 0.00% |
APAM | 41.71% | $3.00B | +3.24% | 6.53% |
PLRX | 41.69% | $682.17M | -32.87% | 0.00% |
RXRX | 41.55% | $2.55B | -32.19% | 0.00% |
ZD | 41.37% | $2.35B | -18.56% | 0.00% |
OUT | 41.36% | $3.06B | +45.50% | 4.67% |
ADMA | 41.18% | $3.79B | +219.76% | 0.00% |
MMI | 41.04% | $1.42B | -2.84% | 1.35% |
BN | 40.87% | $87.76B | +46.18% | 0.55% |
BNT | 40.86% | $7.48B | +46.01% | 0.00% |
PGRE | 40.75% | $991.89M | -8.43% | 1.53% |
VAC | 40.42% | $2.97B | +2.67% | 3.59% |
ALEX | 40.20% | $1.27B | -1.18% | 5.05% |
BAM | 39.84% | $23.32B | +42.34% | 2.72% |
BXP | 39.67% | $11.57B | +7.11% | 5.31% |
Current Value
$14.271 Year Return
Current Value
$14.271 Year Return
Finnhub
Dr. Markus will oversee Arcus’s clinical development organization and portfolio that includes seven clinical-stage programs with multiple ongoing Phase 3 studies ...
SeekingAlpha
Discover investment opportunities in lesser-covered stocks like Arcus Biosciences, Sarepta Therapeutics, and Edison International.
SeekingAlpha
Read here for more on the potential of RCUS's combination therapies for various cancers, with promising Phase 3 trials and impressive overall survival rates in NSCLC.
SeekingAlpha
Invest in Arcus Biosciences for a strong buying opportunity with promising data, robust pipeline, and significant market potential, backed by Gilead's...
Yahoo
Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Yahoo
HAYWARD, Calif., December 24, 2024--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted four new employees options to purchase a total of 66,900 shares of the Company’s common stock at an exercise price per share of $15.96, which was the closing price on December 23, 2024,
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -17.90% | $21.85M | +7.05% | 0.00% |
CBOE | -14.44% | $20.39B | +5.07% | 1.21% |
K | -10.90% | $28.19B | +51.64% | 2.76% |
IMRN | -7.83% | $12.46M | +19.44% | 0.00% |
FATBB | -7.79% | $84.89M | -14.53% | 11.50% |
SYPR | -6.64% | $44.66M | -10.60% | 0.00% |
UUU | -6.62% | $5.34M | +46.20% | 0.00% |
BTCT | -5.91% | $41.51M | +100.97% | 0.00% |
BACK | -5.57% | $2.66M | -34.65% | 0.00% |
OXBR | -5.30% | $26.93M | +332.50% | 0.00% |
CCEC | -4.62% | $1.04B | +3.59% | 3.20% |
KDP | -4.53% | $42.89B | -0.85% | 2.81% |
FAT | -4.48% | $94.35M | -16.69% | 10.09% |
AMN | -4.47% | $985.73M | -65.10% | 0.00% |
MANU | -4.41% | $2.71B | -22.17% | 0.00% |
TK | -4.36% | $681.42M | +1.48% | 0.00% |
HIHO | -4.06% | $8.45M | -5.02% | 6.25% |
VSTA | -3.94% | $194.82M | -40.88% | 0.00% |
PULM | -3.60% | $22.32M | +245.20% | 0.00% |
TEN | -3.48% | $551.75M | -23.11% | 8.06% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AQB | -0.02% | $3.07M | -58.39% | 0.00% |
TXO | 0.09% | $793.31M | +4.53% | 12.21% |
EDSA | -0.20% | $5.90M | -61.01% | 0.00% |
FIVN | -0.35% | $2.81B | -51.57% | 0.00% |
CYD | 0.36% | $424.11M | +17.95% | 3.49% |
STNG | -0.39% | $2.81B | -18.88% | 3.07% |
OMCL | 0.40% | $1.97B | +30.02% | 0.00% |
PSEC | -0.55% | - | - | 15.95% |
SOC | 0.60% | $2.18B | +97.42% | 0.00% |
MRNS | 0.66% | $29.81M | -94.38% | 0.00% |
INSW | -0.66% | $1.89B | -18.20% | 1.25% |
HE | -0.71% | $1.58B | -28.14% | 0.00% |
NEUE | -0.77% | $61.50M | -35.39% | 0.00% |
AGL | 0.93% | $1.27B | -51.49% | 0.00% |
PINS | 0.94% | $20.63B | -17.71% | 0.00% |
RDDT | -0.95% | $30.78B | +415.68% | 0.00% |
LICY | -1.05% | $26.24M | -64.57% | 0.00% |
SUN | -1.17% | $7.42B | -8.19% | 6.29% |
DMLP | 1.23% | $1.57B | +1.88% | 10.44% |
GL | -1.30% | $9.93B | -2.88% | 0.81% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -33.99% | $195.31M | 0.85% |
TAIL | -24.56% | $65.49M | 0.59% |
USDU | -18.48% | $397.27M | 0.5% |
TPMN | -13.62% | $34.33M | 0.65% |
UUP | -10.60% | $642.45M | 0.77% |
UNG | -10.17% | $852.27M | 1.06% |
CTA | -8.71% | $555.39M | 0.76% |
DBE | -4.81% | $51.45M | 0.77% |
JUCY | -4.11% | $300.65M | 0.6% |
KRBN | -3.63% | $192.50M | 0.85% |
DBO | -2.95% | $219.60M | 0.77% |
IVOL | -2.86% | $457.14M | 1.02% |
XHLF | -2.43% | $945.68M | 0.03% |
IBTF | -1.52% | $2.23B | 0.07% |
COMT | -0.68% | $722.55M | 0.48% |
ULST | -0.60% | $554.46M | 0.2% |
GSG | -0.40% | $1.07B | 0.75% |
CORN | -0.39% | $64.82M | 0.2% |
CLOI | -0.11% | $810.07M | 0.4% |
SOYB | 0.22% | $26.94M | 0.22% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CLOI | -0.11% | $810.07M | 0.4% |
SOYB | 0.22% | $26.94M | 0.22% |
USCI | 0.23% | $204.06M | 1.07% |
IBMN | 0.35% | $473.66M | 0.18% |
CORN | -0.39% | $64.82M | 0.2% |
GSG | -0.40% | $1.07B | 0.75% |
DBA | 0.55% | $807.60M | 0.93% |
ULST | -0.60% | $554.46M | 0.2% |
COMT | -0.68% | $722.55M | 0.48% |
XONE | 1.25% | $577.39M | 0.03% |
AGZD | 1.34% | $148.39M | 0.23% |
IBTF | -1.52% | $2.23B | 0.07% |
XBIL | 1.80% | $648.37M | 0.15% |
BUXX | 1.92% | $197.72M | 0.25% |
IBTG | 2.13% | $1.65B | 0.07% |
VRIG | 2.28% | $1.20B | 0.3% |
XHLF | -2.43% | $945.68M | 0.03% |
MSOS | 2.79% | $447.20M | 0.83% |
IVOL | -2.86% | $457.14M | 1.02% |
PDBC | 2.89% | $4.49B | 0.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 55.39% | $6.10B | 0.35% |
IBB | 52.86% | $6.26B | 0.45% |
GNOM | 51.95% | $67.06M | 0.5% |
PTH | 51.90% | $119.40M | 0.6% |
QQA | 50.57% | $147.14M | 0% |
RSPA | 49.97% | $274.39M | 0% |
IWO | 49.57% | $12.85B | 0.24% |
VTWO | 48.32% | $12.58B | 0.1% |
XPH | 48.13% | $165.13M | 0.35% |
IWC | 48.10% | $960.97M | 0.6% |
IWM | 48.03% | $73.09B | 0.19% |
ARKG | 47.91% | $1.10B | 0.75% |
ISCG | 47.55% | $654.62M | 0.06% |
NUSC | 47.48% | $1.26B | 0.31% |
SMMD | 47.26% | $1.40B | 0.15% |
ESML | 47.13% | $1.93B | 0.17% |
VBK | 46.94% | $20.10B | 0.07% |
QQQJ | 46.85% | $667.94M | 0.15% |
VB | 46.79% | $65.21B | 0.05% |
PRFZ | 46.76% | $2.59B | 0.39% |